Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO. Miralbell R, et al. Among authors: van glabbeke m. J Clin Oncol. 1999 Oct;17(10):3143-9. doi: 10.1200/JCO.1999.17.10.3143. J Clin Oncol. 1999. PMID: 10506611 Clinical Trial.
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M, Piérart M. Bernier J, et al. Among authors: van glabbeke m. Radiother Oncol. 2000 May;55(2):111-9. doi: 10.1016/s0167-8140(00)00165-1. Radiother Oncol. 2000. PMID: 10799722 Clinical Trial.
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
Bosset JF, Horiot JC, Hamers HP, Cionini L, Bartelink H, Caspers R, Untereiner M, Ciambelloti E, Pierart M, Van Glabbeke M. Bosset JF, et al. Among authors: van glabbeke m. Radiother Oncol. 2001 Oct;61(1):7-13. doi: 10.1016/s0167-8140(01)00419-4. Radiother Oncol. 2001. PMID: 11578723 Clinical Trial.
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects.
Van den Bogaert W, van der Schueren E, Horiot JC, De Vilhena M, Schraub S, Svoboda V, Arcangeli G, de Pauw M, Van Glabbeke M. Van den Bogaert W, et al. Among authors: van glabbeke m, van der schueren e. Radiother Oncol. 1995 May;35(2):91-9. doi: 10.1016/0167-8140(95)01538-r. Radiother Oncol. 1995. PMID: 7569030 Clinical Trial.
The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma.
Letschert JG, Lebesque JV, Aleman BM, Bosset JF, Horiot JC, Bartelink H, Cionini L, Hamers JP, Leer JW, van Glabbeke M. Letschert JG, et al. Among authors: van glabbeke m. Radiother Oncol. 1994 Aug;32(2):116-23. doi: 10.1016/0167-8140(94)90097-3. Radiother Oncol. 1994. PMID: 7972904 Review.
Age is not a limiting factor for radical radiotherapy in pelvic malignancies.
Pignon T, Horiot JC, Bolla M, van Poppel H, Bartelink H, Roelofsen F, Pene F, Gerard A, Einhorn N, Nguyen TD, Vanglabbeke M, Scalliet P. Pignon T, et al. Radiother Oncol. 1997 Feb;42(2):107-20. doi: 10.1016/s0167-8140(96)01861-0. Radiother Oncol. 1997. PMID: 9106920 Clinical Trial.
EORTC guidelines for writing protocols for clinical trials of radiotherapy.
Bolla M, Bartelink H, Garavaglia G, Gonzalez D, Horiot JC, Johansson KA, van Tienhoven G, Vantongelen K, van Glabbeke M. Bolla M, et al. Among authors: van glabbeke m, van tienhoven g. Radiother Oncol. 1995 Jul;36(1):1-8. doi: 10.1016/0167-8140(95)01573-y. Radiother Oncol. 1995. PMID: 8525020
164 results